Concept
rheumatology
Parents
Children
Childhood ArthritisInflammatory ArthritisLupusRheumatic DiseasesScleroderma
64.7K
Publications
3.2M
Citations
187.3K
Authors
14.3K
Institutions
Steroid-Driven Rheumatoid Arthritis Criteria
1931 - 1960
Rheumatoid arthritis during 1931-1960 is characterized by a systemic disease conception, where vascular pathology and non-articular tissue involvement broaden the research agenda beyond joints. Immunoserology and the search for serologic biomarkers become central to diagnosis and prognosis, informing laboratory approaches and patient stratification. Endocrine modulation and early corticosteroid therapy redefine management, while attention to infectious triggers and preventive strategies fosters a preventive paradigm; pathology reveals lesion patterns in muscle, spine, and other tissues that extend disease biology beyond synovitis.
• Systemic organ involvement and vascular pathology unify rheumatoid arthritis across organ systems, highlighting arteritis, vascular lesions, and cardiac manifestations as core disease processes [4], [5], [6], [7], [12].
• Immunoserology reveals autoantibody-like responses and serologic biomarkers with multiple hemagglutination studies and serum protein analyses shaping autoimmune understanding in RA [10], [11], [14], [17], [19].
• Endocrine modulation and therapeutic criteria influenced early RA management, integrating adrenal cortex hormone effects with guideline-like treatment criteria to guide responses [3], [8].
• Infectious factors and preventive strategies anchor a preventive paradigm, linking streptococcal infections to rheumatic activity and supporting prophylaxis to reduce recurrences [9], [13], [16].
• Pathology-focused lesion patterns illuminate disease biology, from arteritis of striated muscle to vertebral nodules and febrile rheumatism tissue changes, highlighting non-joint pathology [1], [15], [20].
Immunoserology-Driven Rheumatology
1961 - 1970
Immunopathology of Inflammatory Arthritis
1971 - 1977
Immunogenetic Autoimmunity
1978 - 1984
Immunobiology-Driven Arthritis Therapies
1985 - 1999
Targeted Biologic Immunotherapy
2000 - 2006
IL-6–centered therapeutics and classification
2007 - 2013
Mechanistic Treat-to-Target
2014 - 2023